Gefitinib-associated Propionibacterium acnes pleural empyema.
de Prost
Nicolas
N
Lavolé
Armelle
A
Taillade
Laurent
L
Wislez
Marie
M
Cadranel
Jacques
J
D000230:Adenocarcinoma / Q000175:diagnosis / Q000628:therapy; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016724:Empyema, Pleural / Q000382:microbiology* / Q000628:therapy; D005260:Female; D000077156:Gefitinib; D016908:Gram-Positive Bacterial Infections / Q000382:microbiology* / Q000628:therapy; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000628:therapy; D008875:Middle Aged; D018700:Pleurodesis; D011425:Propionibacterium acnes; D011799:Quinazolines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib